Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yafit Segman
Observed name:
Y. Segman
Institutions:
Ben-Gurion University of the Negev,
Assuta Medical Center
Observed institutions:
Ben-Gurion University of the Negev,
Tel Aviv University,
Tel Aviv Sourasky Medical Center,
Assuta Medical Center,
Soroka Medical Center
ORCID:
0000-0002-9059-3887
Observed ORCID:
0000-0002-9059-3887
OpenAlex ID:
A5048789458
Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience
2020
·
Yafit Segman
, Elena Ribakovsky
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
36
Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab
2023
·
Tal Brosh-Nissimov
, Nir Ma'aravi
, et al.
·
Journal of Microbiology Immunology and Infection
·
28
An international multicenter study comparing COVID ‐19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab
2024
·
Tali Shafat
, Daniel Grupel
, et al.
·
Cancer Medicine
·
8
PDF
Outcome of Relapsed DLBCL Patients, Treated with Polatuzumab-BR or Polatuzumab-R: Real Life Data
2019
·
Yafit Segman
, Elena Ribakovsky
, et al.
·
Blood
·
5
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study
2024
·
Hovav Azuly
, Tali Shafat
, et al.
·
Infectious Diseases and Therapy
·
4
PDF
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL—a matched cohort analysis
2022
·
Irit Avivi
, Chava Perry
, et al.
·
Annals of Hematology
·
4
Mitigating the interference of Daratumumab with immunofixation electrophoresis. A single-center experience using Hydrashift 2/4 kit.
2022
·
Adrian Duek
, Emmanuel Lellouche
, et al.
·
PubMed
·
3
P571: Outpatient Initiation of Venetoclax-azacitidine for Selected Acute Myeloid Leukemia Patients Is Feasible and Safe: a Real World Single Center Analysis
2023
·
Roi Gat
, Miri Neeman
, et al.
·
HemaSphere
·
2
[prolonged Post-covid-19 Anemia].
2022
·
Yafit Segman
, Adrian Duek
, et al.
·
PubMed
·
2
Lymphoproliferative disease detected by breast cancer screening
2022
·
Efrat Luttwak
, Yafit Segman
, et al.
·
Journal of Medical Screening
·
1
531 | Adjustment of Chemotherapy Duration According to Peripheral Blood or Bone Marrow Minimal Residual Disease Status in Patients With Follicular Lymphoma
2025
·
U. Abadi
, N. Dally
, et al.
·
Hematological Oncology
PDF
2654. International Multi-Center Study Comparing the Effect of Obinutuzumab or Rituximab Treatment in Hematological Patients on COVID-19 Outcomes During the Omicron Surge
2023
·
Tal Shafat
, Daniel Grupel
, et al.
·
Open Forum Infectious Diseases
PDF
P560: Improvement in Overall and Relapse Free Survival of Aml Patients Over the Age of 75 Since the Approval of Venetoclax in a Real-world Single Center Study.
2023
·
Yakir Moshe
, Shai Levi
, et al.
·
HemaSphere
Multiple Myeloma with Systemic Amyloidosis: Serum Free Light Chain Dimerization Analysis in the Diagnosis of an Equivocal Case of Plasma Cell Dyscrasia.
2021
·
Adrian Duek
, Batia Kaplan
, et al.
·
PubMed
Show more works
View as search
Works count:
14
Citation count:
93
H-index:
4
I10-index:
2
Year
Topic
Type